Author:
Couce María L.,Vitoria Isidro,Aldámiz-Echevarría Luís,Fernández-Marmiesse Ana,Roca Iria,Llarena Marta,Sánchez-Pintos Paula,Leis Rosaura,Hermida Alvaro
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference42 articles.
1. Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376:1417–27.
2. Martínez-Pardo M, Marchante C, Dalmau J, Pérez M, Bellón C. Protocolo de diagnóstico, tratamiento y seguimiento de las hiperfenilalaninemias. An Esp Pediatr. 1998;114:3–18.
3. Okano Y, Nagasaka H. Optimal serum phenylalanine for adult patients with phenylketonuria. Mol Genet Metab. 2013;110:424–30.
4. Mirás A, Bóveda MD, Leis MR, Mera A, Aldámiz-Echevarría L, Fernández- Lorenzo JR, Fraga JM, Couce ML. Risk factors for developing mineral bone disease in phenylketonuric patients. Mol Genet Metab. 2013;108:149–54.
5. Giovannini M, Verduci E, Salvatici E, Paci S, Riva E. Phenylketonuria: nutritional advances and challenges. Nutr Metab. 2012;9:1–7.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献